tyloxapol has been researched along with Hyperlipoproteinemia Type IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Dall'Aglio, E; Hoffman, BB; Hollenbeck, C; Reaven, GM | 1 |
1 other study(ies) available for tyloxapol and Hyperlipoproteinemia Type IV
| Article | Year |
|---|---|
Suppression of free fatty acids and triglycerides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladenosine.
Topics: Adenosine; Animals; Fatty Acids, Nonesterified; Hyperlipoproteinemia Type IV; Lipolysis; Lipoproteins, VLDL; Male; Phenylisopropyladenosine; Polyethylene Glycols; Rats; Rats, Inbred Strains; Receptors, Purinergic; Triglycerides | 1986 |